Samsara BioCapital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001744967

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2024 · 43 positions · Total reported value $728.58M · Top-10 concentration 81.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.0% · 3 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2024 13F filing, Samsara BioCapital, LLC disclosed 43 equity positions with a combined reported value of $728.58M. The filing implies a focused portfolio: its ten largest positions account for 81.8% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were SRRK ($242.59M), CRGX ($63.67M), SEPN ($63.40M). By sector, the heaviest allocations are Health Care 84.3%, Other 15.7%. Versus the prior quarter, allocation shifted toward Health Care (+15.8pp) and away from Other (-15.8pp).

Versus the prior quarter, Samsara BioCapital, LLC opened 3 new positions, trimmed 7 and fully exited 0, a turnover rate of 37.0% of positions. The portfolio's overlap with the prior quarter was 81% of names.

The largest new positions opened in Q4 2024 were SEPN ($63.40M), UPB ($36.45M), PVLA ($8.15M).

Of the 4 positions fully exited versus the prior quarter, the largest were SYRS ($3.84M), IOBTQ ($3.82M), BCAX ($891.45K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • SEPN SEPTERNA INC · $63.40M
  • UPB UPSTREAM BIO INC · $36.45M
  • PVLA PALVELLA THERAPEUTICS INC NE · $8.15M
  • OKUR ONKURE THERAPEUTICS INC · $7.09M
  • CRIS CURIS INC · $606.54K

Fully Exited (vs previous quarter)

  • SYRS SYROS PHARMACEUTICALS INC · prev qtr: $3.84M
  • IOBTQ IO BIOTECH INC · prev qtr: $3.82M
  • BCAX BICARA THERAPEUTICS INC · prev qtr: $891.45K
  • VIRX VIRACTA THERAPEUTICS INC · prev qtr: $159.60K

Insider Transactions (Form 4)

Latest Samsara BioCapital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Samsara BioCapital, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 27 positions worth $1.05B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • SEC registration: 801-113741 (status: Approved), registered 2018-07-27
  • Regulatory AUM (Form ADV): $2.17B as of 2026-10-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds

Portfolio Structure

  • 27 positions · $1.05B reported value (Q3 2026)
  • Top 10 holdings = 87.9% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 31.7%
  • Average position size: $38.95M

Sector Tilt

  • Health Care 91.8%
  • Industrials 8.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 3 new, 3 added, 7 reduced
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 84.3%
Other 15.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.61M $242.59M 33.30%
33.30%
Reduce
2 4.42M $63.67M 8.74%
8.74%
Hold
3 2.77M $63.40M 8.70%
8.70%
New
4 5.07M $62.47M 8.57%
8.57%
Hold
5 1.72M $39.25M 5.39%
5.39%
Add
6 2.22M $36.45M 5.00%
5.00%
New
7 986.98K $28.49M 3.91%
3.91%
Reduce
8 3.27M $25.67M 3.52%
3.52%
Hold
9 253.64K $19.45M 2.67%
2.67%
Reduce
10 1.00M $14.64M 2.01%
2.01%
Hold
11 584.64K $12.50M 1.72%
1.72%
Hold
12 967.53K $10.17M 1.40%
1.40%
Hold
13 172.65K $9.66M 1.33%
1.33%
Hold
14 3.77M $9.38M 1.29%
1.29%
Hold
15 588.82K $8.63M 1.18%
1.18%
Hold
16 679.49K $8.15M 1.12%
1.12%
New
17 2.52M $7.92M 1.09%
1.09%
Hold
18 824.15K $7.09M 0.97%
0.97%
New
19 2.44M $7.02M 0.96%
0.96%
Hold
20 850.00K $6.22M 0.85%
0.85%
Hold
21 2.39M $5.91M 0.81%
0.81%
Add
22 6.13M $5.55M 0.76%
0.76%
Hold
23 2.61M $4.70M 0.65%
0.65%
Hold
24 97.62K $4.53M 0.62%
0.62%
Reduce
25 1.56M $4.33M 0.59%
0.59%
Hold
26 2.20M $4.04M 0.56%
0.56%
Hold
27 291.67K $2.94M 0.40%
0.40%
Hold
28 206.78K $2.86M 0.39%
0.39%
Hold
29 630.00K $1.95M 0.27%
0.27%
Hold
30 147.32K $1.87M 0.26%
0.26%
Hold
31 198.00K $1.41M 0.19%
0.19%
Hold
32 405.23K $1.18M 0.16%
0.16%
Reduce
33 202.35K $1.12M 0.15%
0.15%
Hold
34 399.64K $827.25K 0.11%
0.11%
Reduce
35 198.22K $606.54K 0.08%
0.08%
New
36 11.26K $603.02K 0.08%
0.08%
Reduce
37 1.05M $561.40K 0.08%
0.08%
Hold
38 1.97M $405.72K 0.06%
0.06%
Reduce
39 172.09K $208.23K 0.03%
0.03%
Hold
40 78.13K $74.22K 0.01%
0.01%
Hold
41 82.34K $34.58K 0.01%
0.01%
Hold
42 133.33K $30.67K 0.00%
0.00%
Hold
43 100.00K $2.14K 0.00%
0.00%
Hold

FAQ

What did Samsara BioCapital, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, Samsara BioCapital, LLC reported 43 equity positions worth $728.58M in aggregate; its largest disclosed positions were SRRK ($242.59M), CRGX ($63.67M), SEPN ($63.40M).

How large is Samsara BioCapital, LLC's portfolio?

Samsara BioCapital, LLC reported $728.58M of long equity holdings across 43 positions as of 2024-Q4. Top-10 holdings account for 81.8% of reported value.

What is Samsara BioCapital, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/samsara-biocapital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →